Inogen Inc (INGN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inogen Inc (INGN) has a cash flow conversion efficiency ratio of 0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.17 Million) by net assets ($197.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inogen Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Inogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Inogen Inc for a breakdown of total debt and financial obligations.
Inogen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inogen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ABL Group ASA
OL:ABL
|
0.040x |
|
China Harmony Auto Holding Limited
F:HA5
|
0.043x |
|
Havilah Resources Ltd
AU:HAV
|
-0.010x |
|
JADESTONE ENERGY LS -001
F:8KW
|
N/A |
|
Coastal Contracts Bhd
KLSE:5071
|
-0.027x |
|
LaFayette Acquisition Corp. Ordinary Share
NASDAQ:LAFA
|
0.724x |
|
E-Life Mall Corp
TW:6281
|
0.110x |
|
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
|
0.207x |
Annual Cash Flow Conversion Efficiency for Inogen Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Inogen Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Inogen Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $173.86 Million | $5.91 Million | 0.034x | +315.43% |
| 2023-12-31 | $204.81 Million | $-3.23 Million | -0.016x | +87.49% |
| 2022-12-31 | $297.41 Million | $-37.53 Million | -0.126x | -297.70% |
| 2021-12-31 | $370.23 Million | $23.63 Million | 0.064x | -39.70% |
| 2020-12-31 | $349.62 Million | $37.01 Million | 0.106x | -10.12% |
| 2019-12-31 | $344.62 Million | $40.59 Million | 0.118x | -39.04% |
| 2018-12-31 | $310.42 Million | $59.98 Million | 0.193x | -27.49% |
| 2017-12-31 | $227.04 Million | $60.49 Million | 0.266x | +56.33% |
| 2016-12-31 | $182.09 Million | $31.03 Million | 0.170x | -40.15% |
| 2015-12-31 | $134.02 Million | $38.16 Million | 0.285x | +114.33% |
| 2014-12-31 | $118.15 Million | $15.70 Million | 0.133x | -44.46% |
| 2013-12-31 | $56.30 Million | $13.47 Million | 0.239x | +70.71% |
| 2012-12-31 | $28.57 Million | $4.00 Million | 0.140x | -43.05% |
| 2011-12-31 | $7.56 Million | $1.86 Million | 0.246x | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term ox… Read more